报告作者：Jacob Plieth    报告出处：Vantage
相关股票：$ Juno Therapeutics (JUNO)$ $Kite Pharma(KITE)$

To say that recent progress in CAR-T therapies was greeted

with market enthusiasm last year could be the understatement

of 2014. And as 2015 gets under way this area looks set to be

one of the top investment themes of the year.
网页链接